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Multidisciplinary teams of clinicians manage patients with
head and neck cancer in the UK. The lead clinician for any
particular patient is likely to be either a surgeon or an
oncologist but they rely on the skills of many health care
professionals for both diagnostic and therapeutic purposes.
This paper outlines the role of the surgeon within the head
and neck cancer team, their key tasks and responsibilities.
Throughout, it enumerates the surgeon’s requirements from
diagnostic radiological colleagues.
Introduction and background
The term ‘head and neck cancer’ covers a large number
of diﬀerent epithelial tumours that arise at a number of
sites (Table 1). Excluding skin cancers, the majority of
these tumours develop in the upper aero-digestive tract.
Approximately 4500 people develop cancer of the
upper aero-digestive tract every year in the UK and a
further 900 present with cancer of the thyroid gland.
Head and neck cancer is therefore relatively uncommon
in comparison to cancer of the lower airway and gas-
trointestinal tract. Head and neck cancer represents
about 2.5% of all cancer registrations in the UK each
and every year. The incidence of head and neck cancer
within the UK is not uniform. Regional variations are
apparent that range from 7.7 per 100 000 population in
South East Thames to 15.3 per 100 000 population in
Wales. The cause of these regional variations is not
entirely clear but, to some extent, reflects social class and
habits, as squamous cell cancer of the upper aero-
digestive tract is a smoking-related disease. Cigarette-
smokers have a 14-fold increased risk of developing
laryngeal cancer[1]. Alcohol further increases the risk of
developing cancer at these sites particularly in the oral
cavity, hypopharynx, oesophagus and supraglottis.
There is also a well-recognized occupational hazard for
hard-wood workers who have the misfortune to develop
adenocarcinoma of the nasal cavity. Dietary deficiencies,
occupational exposure to asbestos, nickel and other
industrial chemicals have also been implicated, but the
relative risk conferred by these factors is probably not as
great as previously thought.
Initial management of the primary
tumour
Even though the majority of head and neck cancers are
of the same histological type, squamous cell carcinoma,
treatments diﬀer according to the site, stage and the
patient’s preference or particular needs. At the outset,
the principal task for the surgeon is the accurate diag-
nosis and staging of the patient’s tumour. Tissue for
histological diagnosis must be obtained from the pri-
mary site, if known, by either open biopsy or fine-needle
biopsy, which may need to be image-guided. Factors
that might influence outcome or suitability for treatment
must be investigated and documented. Careful imaging
at this point in the patient’s management is crucial. The
relationship of the tumour to adjacent structures, the
nodal status of the neck and the presence of other
unsuspected primary neoplasms or metastases in the
neck, chest or liver have a significant impact on treat-
ment planning and outcome. Site-specific imaging pro-
tocols have been developed and published in a national
consensus document[2]. To complicate matters further,
some patients present with metastatic neck disease for
which no primary site is apparent. About 75% of these
tumours will have developed from head and neck prima-
ries and only 11% from primaries outside that region[3,4].
The origin of some is never determined. CT, MR and
PET scanning can be extremely helpful in the assessment
and management of these patients.
Table 1 The most common primary sites at which cancer
is found in the head and neck in the United Kingdom and
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Treatment options and the
development of a management plan
Most small tumours are amenable to radiotherapy or
local excision, while larger tumours require combination
therapies for control and best prospect of cure. The
upper aero-digestive tract and its functions are often
deranged by surgical interventions and this can have an
enormous impact on the patient’s quality of life, not-
withstanding the best services and skills of speech and
swallowing therapists. It is the surgeon’s responsibility
to inform the patient and their carer about the cancer in
terms that they can understand and to explain methods
of treatment or palliation so that the right decision is
made and fully informed consent can be obtained.
Detailed and accurate imaging of the patient and their
disease is fundamental to this process. Furthermore,
interventional techniques have made surgical resection
safer and some radiological procedures can facili-
tate post-operative care; for example, pre-operative
embolization of vascular tumours and percutaneous
gastrostomy. Image-guidance during surgery is becom-
ing more popular and will undoubtedly have a positive
impact on the management of patients with neoplasms
infiltrating, or arising in, the skull base. Table 2 outlines
the key tasks and questions a surgeon may ask of their
radiologist.
Post-operative care
After treatment, the surgeon is responsible for continu-
ing care. It is the surgeon’s duty to review their patient
until it is reasonable to assume that the cancer will not
recur, any disabilities have been adequately managed or,
in the case of recurrent or incurable disease, the patient
no longer requires surgical intervention. Interval scan-
ning is pivotal in this process, particularly for skull base
tumours and thyroid cancers.
Finally, it is important to remember that 15–25% of
patients with primary squamous cell carcinomas of the
head and neck develop second primary tumours in the
same region within 5 years and 10–30% of these patients
will develop third and fourth primaries in the head and
neck. Modern imaging techniques have improved the
detection and clinical staging of these tumours, which
in turn should have an impact on survival for these
unfortunate patients.
Key points
(1) The surgeon is ultimately responsible for the
management of patients with head and neck cancer
(2) Detailed imaging of the head and neck is required in
the initial assessment of the patient
(3) Interventional techniques can facilitate surgical
procedures and post-operative care
(4) Interval scanning in the post-operative period is
often requested to assess response to treatment and
to detect recurrence or second primary tumours
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